Patient Recruitment in Oncology Trials: Understanding the Patient’s Perspective, Upcoming Webinar Hosted by Xtalks

09:00 EDT 19 Aug 2019 | PR Web

Join this free webinar to learn about the importance of the patient perspective in successful oncology clinical trials.

TORONTO (PRWEB) August 19, 2019

In a live session upcoming on Thursday, September 12, 2019 at 10am EDT (3pm BST/UK), experts from Syneos Health will discuss:

  • Insights into tools and methods to enhance understanding where patient recruitment for a trial fits into treatment pathways
  • Recognizing patient emotional pathways and their impact on optimized treatment pathways
  • Ways to target efforts in identifying patients for patient recruitment, to support patient and caregiver engagement
  • Optimizing/Targeting the information for patients and recruiting sites to support more effective patient recruitment outcomes

Although the percentage varies by country, only a small fraction — an estimated 8.1 percent — of patients participate in oncology clinical trials. Reasons for not participating vary by patient, but some key reasons cited include lack of patient awareness about available trials, communications challenges in the recruitment process, desire to remain with the “standard of care”, or study protocol misalignment with patient needs.

Given the high unmet patient need, sites must understand the patient journey from their perspective and strive to meet patients where they are to recruit patients effectively. When evaluating this journey, it is important to look beyond the treatment pathway; focusing on the course of the disease, to their emotional pathway — including how they are responding physically and emotionally, when and where they seek support and where they find information. Understanding this emotional pathway provides crucial insights into the uniqueness of each patient.

Patient participation in oncology trials ultimately requires a thoughtful discussion between the patient, influencing caregivers, the investigator and their primary oncologist. Tools, such as social listening, insights from physicians and conversations with patient advocacy groups can inform and optimize recruitment strategies. Conversations with these patients should acknowledge their declining emotional strength and the role of others in their support network in decisions related to any participant in a trial.

Understanding exactly how patient recruitment for any trial should fit into both the treatment and emotional pathway helps investigative sites determine where they should look for patients — whether these are internal or external referrals.

A Q&A session with the audience will follow the live presentation. For more information or to register for this free event, visit Patient Recruitment in Oncology Trials: Understanding the Patient’s Perspective.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit

For the original version on PRWeb visit:


More From BioPortfolio on "Patient Recruitment in Oncology Trials: Understanding the Patient’s Perspective, Upcoming Webinar Hosted by Xtalks"

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...